Theses

Date	Theses

29-11-2022	Fajri Gafar Optimization of tuberculosis treatment in children and adolescents. Epidemiological and pharmacological approaches.	Prof. Katja Taixs
31-10-2022	Johanne Rozema Real-world studies of patients with myelodysplastic syndromes. Survival, treatment and outcomes in a population-based setting	Prof. Eric van Roon
19-9-2022	Tanja Fens- Lazova Perspectives on medication safety and use. Pharmacoeconomics, public policy & practice and pharmacists education.	Prof. Maarten Postma Prof. Eugène van Puijenbroek
15-3-2022	Joep Scholl Signal detection in Pharmcovigilance. Time for a new era?	Prof. Eugène van Puijenbroek Prof. Eelko Hak
15-10-2021	Nanno Schreuder Exploring drug safety of radiopharmaceuticals.	Prof. Eugène van Puijenbroek Prof. Jos Kosterink
11-10-2021	Berdien Oortgiesen Real-worl studies of patients with mutiple myeloma. Future perspectives on symptom assessment and therapy.	Prof. Eric van Roon
27-11-2020	Karin Larmené Beld Ready to administer parental medication produced by hospital pharmacy	Prof. K. Taxis Prof. M.J. Postma Prof. H.W. Frijlink
12-10-2020	Sylvi Irawati Challenges in the use of preventive cardiovascular medications in Indonesia and The Netherlands	Sylvi Irawati Prof. E. Hak Prof. K. Taxis
06-10-2020	Sofa Dewi Alfian Adherence to antihypertensive or antihyperlipidemic co-medications in diabetis	Prof. E. Hak Prof P. Denig
08-05-2020	Yuanyuan Wang Effectiveness and safety of medicines used in COPD patients: pharmacoepidemiological studies	Prof. E. Hak Prof. M. Boezen
24-02-2020	Ivan Pradipta Improving treatment outcomes of tuberculosis: towards an antimicrobial stewardship program	Prof. E. Hak Prof. J.W. Alffenaar
10-02-2020	Ira Sianturi Exploring strategies to optimize pharmacotherapy with antiretrovirals in Papuans living with HIV	Prof. K. Taxis Prof. B. Wilffert
2019-03-22	Heleen van der Meer Prof dr K Taxis Prof dr LG Pont Describing in older people. Development and evaluation of complex healthcare interventions
2018-12-21	Willem van der Veen Prof dr K Taxis Prof dr PMLA van den Bemt Prof dr JJ de Gier Information technology and medication safety
2018-11-30	Mirjam Simoons Prof dr EN van Roon Prof dr RA Schoevers Somatic monitoring of patients with mood and anxiety disorders: Problem definition, implementation and further explorations
2018-09-14	Maarten van Wijhe Prof dr MJ Postma Prof dr J Wallinga The public health impact of vaccination programmes in the Netherlands
2018-06-29	Ury Arifin Prof dr MJ Postma Distress and health-related quality of life in Indonesian type 2 diabetes mellitus outpatients
2018-06-25	Neily Zakiyah Prof dr MJ Postma Women's health from a global economic perspective
2018-03-23	Leàn Rolfes Prof dr EP van Puijenbroek Prof dr K Taxis Patient participation in pharmacovigilance
2018-03-16	Thang Nuyen Prof dr K Taxis Prof dr B Wilffert Prof de TT Pham Medication use for acute coronary syndrome in Vietnam
2018-01-26	Eva van Doorn Prof dr E Hak Prof dr ALW Huckriede Improving influenza prevention. Why universal influenza vaccines are needed
2017-08-12	Jurjen van der Schans Prof dr E Hak Prof dr PJ Hoekstra Dr TW de Vries ADHD and atopic diseases. Pharmacoepidemiological studies
2017-06-02	Jan Peter Yska Prof dr EN van Roon Prof dr B Wilffert Exploring optimal pharmacotherapy after bariatric surgery: where two worlds meet
2017-04-24	Nur Aizati Athirah Daud Prof dr B Wilffert Dr JEH Bergman Paving ways for personalizing drug therapy during pregnancy
2017-02-17	Didik Setiawan Prof dr MJ Postma Prof dr B Wilffert HPV vaccination in Indonesia: A health-economic & comparative perspective
2016-12-09	Nyashadzaishe Mafirakureva Prof dr MJ Postma Dr M van Hulst Dr S Khoza Health economics of blood transfusion in Zimbabwe
2016-12-09	Tonderai Mapako Prof dr MJ Postma Dr M van Hulst Risk modelling of transfusion transmissible infections
2016-11-18	Renata Šmit Prof dr MJ Postma Prof dr K Poelstra Health economics of tick-borne diseases
2016-09-23	Lan Nguyen Prof dr MJ Postma Dr CCM Schuiling-Veninga Dr Nguyen Thi Bach Yen Dr EP Wright Health economics of screening for hypertension in Vietnam
2016-09-12	Jovan Mihajlović Prof dr MJ Postma Dr P Pechlivanglou Health economics of targeted cancer therapies: A comparative analysis for Serbia and the Netherlands
2016-06-21	Maryam Darvishian Prof dr E Hak Prof dr ER van den Heuvel Real-world influenza vaccine effectiveness: New designs and methods to adjust for confounding and bias
2016-06-17	Hans-Joerg Fugel Prof dr MJ Postma Dr M Nuijten Dr K Redekop Economics of stratified medicine
2016-06-17	Lisette Berm Prof dr B Wilffert Prof dr E Hak Optimizing treatment with psychotropic agents through precision drug therapy: It is not about the mean
2016-03-11	Maarten Bijlsma Prof dr E Hak Prof dr S Vansteelandt Age-period-cohort methodology: Confounding by birth cohort in cardiovascular pharmacoepidemiology
2016-03-02	Linda de Jong Prof dr IM van Langen Prof dr LTW de Jong- van den Berg Data quality and methodology in studies on maternal medication use in relation to congenital anomalies
2016-02-26	Dianna de Vries Prof dr E Hak Prof dr P Denig Prof dr MJ Postma Statin treatment in type 2 diabetes patients
2016-02-19	Bianca Mulder Prof dr E Hak Prof dr SS Jick Medication use during pregnancy and atopic
2016-01-25	Priscilla Zetstra-van der Woude Prof dr LTW de Jong-van den Berg Data collection on risk factors in pregnancy
2015-12-22	Jelena Stevanovic Prof dr MJ Postma Pharmacoeconomics of cardiovascular disease prevention
2015-12-04	Koen Pouwels Prof dr E Hak Self-controlled designs to control confounding
2015-11-17	Jan Wijnia Prof dr CI Mulder Prof dr AJM Loonen Early detection of mental and motor symptoms in the Wernicke-Korakoff Syndrome
2015-09-25	Job van Boven Prof dr MJ Postma Prof dr T van der Molen Enhancing adherence in patients with COPD: Targets, interventions & cost-effectiveness
2015-09-16	John Pitman Prof dr MJ Postma Prof dr TS van der Werf The influence and impact of the U.S. President's Emergency Plan for AIDS Relief (PERFAR) on blood transfusin services in Africa. Case studies from Namibia
2015-06-26	Marlies Geurts Prof dr JJ de Gier Prof dr JRBJ Brouwers Prof dr PA de Graeff Integrated Pharmaceutical Care. Cooperation between pharmacist, general practioner, and patient and the development of a pharmaceutical care plan
2015-05-29	Nikolas Kotsopoulos Prof dr MJ Postma Dr M Connolly Novel economic perspectives on prevention and treatment: case studies for paediatric, adolescent and adult infectious and chronic diseases
2015-05-29	Bo Standaert Prof dr MJ Postma Prof dr O Ethgen Exploring new ways of measuring the economic value of vaccination with an application to the prevention of rotaviral disease
2015-05-01	Bart Heeg Prof dr MJ Postma Prof dr E Buskens Prof dr BA van Hout Modelling chronic diseases for reimbursement purposes
2014-11-03	Thao Huong Nguyen Prof dr K Taxis Prof dr FM Haaijer-Ruskamp Prof dr JRBJ Brouwers Medication Safety in Vietnamese Hospitals. A focus on medication errors and safety culture
2014-06-27	Auliya Suwantika Prof dr MJ Postma Dr K Lestari Economic evaluations of non-traditional vaccinations in middle-income countries: Indonesia as a reference case
2014-05-28	Giedre Gefenaite Prof dr E Hak Prof dr RP Stolk Newly introduced vaccines. Effectiveness and deterninants of acceptance
2014-04-07	Susana Monteiro Prof dr JJ de Gier Dr ir L van Dijk Driving-impairing Medicines and Traffic Safety. Patients' Perspectives
2013-10-28	Josien Riphagen-Dalhuisen Prof dr E Hak Influenza vaccination of health care workers
2013-10-25	Fenneke van Hasselt Prof dr AJM Loonen Prof dr MJ Postma Dr MJT Oud Dr PFM Krabbe Improving the physical health of people with severe mental illness : the need for tailor made care and uniform evaluation of interventions
2013-09-13	Mehraj Parouty Prof dr MJ Postma Inequality Aversion to Posterity: Discounting Human Lives
2013-06-28	Hoa Dinh Vu Prof dr JRBJ Brouwers Prof dr DRA Uges Prof dr VH Le†/ Prof dr DH Nguyen Clinical Pharmacology of Tuberculosis Drugs and Tuberculosis Control in Developing World. The involvement of Private Pharmacy and the individualization of treatment using Dried blood spot
2013-06-07	Timothy Broesamle Prof dr JJ de Gier Prof dr JJ van der Werf Designing Health Care Services Using Systems Thinking: A Theory, A Method and their Application in the Dutch Community Pharmacy
2013-05-31	Josta de Jong Prof dr LTW de Jong-van den Berg Dr TW de Vries Antibiotic drug use in children. Pharmacoepidemiologic, practical, social en enviromental perspectives in the Netherlands
2013-04-17	Tjalke Westra Prof dr MJ Postma Prof dr JC Wilschut Prof dr CAHH Daemen Prof dr HW Nijman Health-economic Modelling of Human Papillomavirus Vaccination
2013-03-22	Irene Lako Prof dr K Taxis Prof dr D Wiersma Depressive Symptoms in Patients with Schizophrenia. Count symptoms that Count
2013-02-25	Mark Rozenbaum Prof dr MJ Postma Prof dr E Hak Cost and Effectiveness of Extended Vaccination Strategies against Pertussis and Pneumococcal Disease
2013-02-25	Albert Jan van Hoek Prof dr MJ Postma Prof dr WJ Edmunds Prof dr E Miller The Epidemiology and Cost-effectiveness of Vaccination Strategies against Infectious Diseases: a Focus on Varicella Zoster, Pandemic influenza A/H1N1 2009, Streptococcus Pneumonia
2013-01-11	Peter ter Horst Prof dr B Wilffert Prof dr LTW de Jong-van den Berg Clinical Pharmacology of Antidepressants During Pregnancy
2012-12-18	Petros Pechlivanoglou Prof dr MJ Postma Prof dr JE Wierinnga Applying and Extending Mixed-effects Models in Health Economics and Outcomes Research
2012-11-16	Ineke Crijns Prof dr LTW de Jong-van den Berg Drug Related Safety Issues Affecting Precnancy Outcome and Concerning Risk Minimisation Measures. Emphasis on Pregnancy Prevention Programmes
2012-10-10	Janna Munster Prof dr E Hak Prof dr JG Aaarnoudse Q Fever During Pregnancy. Lessons From the Dutch Epidemic
2012-06-04	Linda Harmark Prof dr AC van Grootheest Prof dr JJ de Gier Web-based intensive monitoring : a patient based pharmacovigilance tool
2012-03-16	Stefan Vegter Prof dr MJ Postma Prof dr G Navis The value of personalized approaches to improve pharmacotherapy in renal disease
2012-02-24	Silvia Ravera Prof dr JJ de Gier Prof dr LTW de Jong vd berg Psychotropic medications and traffic safety. Contributions to risk assessment and risk communication
2012-01-27	Hong Anh Thi Tu Prof dr MJ Postma Health economics of new and under-used vaccines in developing countries: state-of-the-art analyses for hepatitis B and rotavirus in Vietnam
2011-12-09	Janneke Boersma-Jentink Prof dr LTW de Jong vd berg Prof dr H Dolk Risk assessment of antiepileptic drugs in pregnancy
2011-11-18	Florence van Hunsel Prof dr AC van Grootheest Prof dr LTW de Jong vd berg The contribution of direct patient reporting to pharmacovigilance
2011-02-04	Evert Jan Mookhoek Prof dr AJM Loonen Prof dr JRBJ Brouwers Patterns of somatic disease in residential psychiatric patients : surveys of dyspepsia, diabetes and skin disease
2011-02-04	Anna Krabbe Lugner Prof dr MJ Postma Dr J Wallinga Cost-effectiveness of controlling infectious diseases from a public health perspective
2010-10-08	Michiel Duyvendak Prof dr JRBJ Brouwers Pharmaceutical care by clinical pharmacists in patients with musculoskeletal disease
2010-04-16	Mark Connolly Prof dr MJ Postma Prof dr W Ledger The Economics of assisted reproduction. Costs and consequences of fertility treatments
2010-01-11	Marian Bakker Prof dr CHCM Buijs Prof dr LTW de Jong vd berg The use of a birth defects case-control monitoring system in studying the safety of medication use in pregnancy
2010-01-08	Susanne Schorr Prof dr K Taxis Prof dr JRBJ Brouwers Drug safety in patients with psychotic disorders
2010-01-08	Robin de Vries Prof dr MJ Postma Prof dr LTW de Jong vd berg Health-economics of interventions aimed at infectious diseases: dynamic modeling inevitable for reliable decision making
2009-11-09	Asmar Al Hadithy Prof dr JRBJ Brouwers Prof dr AJM Loonen Pharmacogenetics of Antipsychotic-Induced Parkinsonism and Tardive Dyskenesia: a Focus on African-Caribbeans and Slavonic Caucasians
2009-06-26	Maarten Beinema Prof dr JRBJ Brouwers Prof dr J vd Meer The optimization of coumarin anticoagulant therapy: Pharmacogenetics and computer assisted dose finding
2009-06-12	Cornelis Boersma Prof dr MJ Postma Prof dr LTW de Jong vd berg Prof dr PE de Jong Health economics of cardiovascular & renal disease prevention : from clinical trials to real-life settings
2009-05-11	Gijs Hubben Prof dr MJ Postma Cost-effectiveness of infectious disease interventions : combining economic modelling and web technology to support decision making
2009-03-20	Fokaline Vroom Prof dr LTW de Jong vd berg Prof dr JRBJ Brouwers Prof dr MAFJ van de Laar Drug use in pregnancy. Exploring the field of DMARDs in pregnancy
2008-11-28	Mark Reinders Prof dr JRBJ Brouwers Prof dr MAFJ vd Laar Practice research in the field of gout. Clinical pharmacology of antihyperuricemic drugs
2008-11-14	Tjalling de Vries Prof dr LTW de Jong vd berg Prof dr EJ Duiverman Improving care in paediatric asthma: patients, prescriptions, pharmacovigilance, pathogens, and particles
2008-10-17	Beitske Smink Prof dr DRA Uges Prof dr ACG Egberts Prof dr jj de Gier Benzodiazepines and traffic safety. Forensic, analytical-toxicological and epidemiological aspects of driving under the influence of benzodiazepines
2006-12-08	Willemijn Meijer Prof dr LTW de Jong vd berg Prof dr JRBJ Brouwers Drug safety in pregnancy. Studying and communicating teratogenic risks
2006-10-02	Adrianne Faber Prof dr LTW de Jong vd berg Stimulant treatment in children: a Dutch perspective
2006-09-15	Jarir Atthobari Prof dr LTW de Jong vd berg Prof dr PE de Jong Drug use in a population screening: Pharmacoepidemiological and pharmacoeconomical aspects
2006-06-30	Rogier Klok Prof dr JRBJ Brouwers Prof dr MJ Postma Pharmacoeconomic Analysis of Proton Pump Inhibitor Therapy and interventions to Control Helicobacter pylori Infection
2005-05-11	Frank Jansman Prof dr JRBJ Brouwers Prof dr DTh Sleijfer Chemotherapy for patients with colorectal Cancer
2005-03-11	Eric van Roon Prof dr JRBJ Brouwers Prof dr MAFJ van de Laar Practice research in the field of rheumatoid arthritis
2004-12-17	Ada Stuurman-Bieze Prof dr LTW de Jong vd berg Dr ThFJ Tromp Interventions on the principle of Pulmonary Medication Profiles
2004-11-19	Andrea Tramarin Prof dr JRBJ Brouwers Dr MJ Postma The changing economic burden of HIV/AIDS in Italy
2004-01-09	Jasper Bos Prof dr LTW de Jong vd berg Dr MJ Postma Pharmacoeconomics in infectious disease. The evaluation of prevention programmes
2003-12-01	Vera Deneer Prof dr JRBJ Brouwers Prof dr JH Kingma Episodic tretment and prevention of paroxysmal atrial fibrilation: studies on flecainide and sotalol
2003-11-18	Kees van Grootheest Prof dr LTW de Jong vd berg Dr EP van Puijenbroek Improving Pharmacovigilance and the Role of the Pharmacist
2003-10-03	Eric Schirm Prof dr LTW de Jong vd berg Dr H Tobi Drug Exposure from conception till adulthood
2003-10-03	Claudia Rijcken Prof dr LTW de Jong vd berg Pharmacy Data as a Tool for assessing Antypsychotic Drug Use
2003-01-31	Taco Monster Prof dr LTW de Jong vd berg Prof dr PE de Jong Dr H Tobi Assessing drug influences on urinary albumin excretion
2002-06-07	Karen van Dijk Prof dr LTW de Jong vd berg Prof JRBJ Brouwers pharmacotherapy in frail elderly
2002-02-22	Patricia van den Bemt Prof dr JRBJ Brouwers Prof dr ACG Egberts Drug safety in hospitalised patients
2001-11-10	Nicolien Wieringa Prof dr R Vos Prof dr PA de Graeff Connecting pre-marketing clinical research and medical practice : the case of the cardiovascular drugs
2001-06-18	Hermien de Walle Prof dr CHCM Buys Prof dr LTW de Jong vd berg Awareness and use of folic acid in the Netherlands: from science to practice
2001-05-04	Roel Fijn Prof dr LTW de Jong vd berg Prof dr JRBJ Brouwers Managing Rational Pharmacotherapy in Hospitals: what about drug formularies and pharmacotherapeutic guidelines?
2001-01-19	Marc Weeber Prof dr R Vos Prof dr LTW de Jong vd berg Literature-based Discovery in Biomedicine
2000-06-21	Jennita Reefhuis Prof dr CHCM Buys Prof dr LTW de Jong vd berg The Use of Birth Defect Registries for Etiological Research.
2000-01-28	Foppe van Mil Prof dr ThFJ Tromp Prof dr LTW de Jong vd berg Prof dr J McElnay Pharmaceutical care, the future of pharmacy
1998-10-16	Corinne de Vries Prof dr LTW de Jong vd berg Prof dr ThFJ Tromp Collaboration in healthcare, the tango to drug safety
1998-01-30	Floor Rikken Prof dr R Vos Prof dr DKF Meijer Prof dr W van Rossum Adverse Drug Reactions in a Different Context; a scientometric approach towards adverse drug reactions as a trigger for the development of new drugs
1995-09-22	Anke van Trigt Prof dr ThFJ Tromp Prof dr MNG Dukes Prof dr FM Haaijer-Ruskamp Dr LTW de Jong vd Berg Making News about Medicines
1995-07-07	Miriam Sturkenboom Prof dr H Wesseling Prof dr DKF Meijer Dr LTW de Jong vd Berg A Field-oriented Postmarketing Surveillance Study on the Teratogen Acitretin
1992-04-29	Lolkje de Jong-van den Berg Prof dr MNG Dukes Prof dr H Wesseling Drug Utilization Studies in Pregnancy; what can they contribute to safety assessment?
1989-12-11	Rein Vos Prof dr DKF Meijer Prof dr AJ Dunning Prof dr TAF Kuipers Dr HWHJ Bodewitz Drugs Looking for Diseases; a descriptive model for the process of innovative drug research with special reference to the development of beta blockers and the calcium antagonists

Laatst gewijzigd:

13 januari 2023 15:40